Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M31,543Revenue $M2,705Net Margin (%)5.4Altman Z-Score4.5
Enterprise Value $M33,766EPS $0.7Operating Margin %22.1Piotroski F-Score3
P/E(ttm)194Beneish M-Score-2.0Pre-tax Margin (%)19.8Higher ROA y-yN
Price/Book3.910-y EBITDA Growth Rate %--Quick Ratio3.0Cash flow > EarningsY
Price/Sales11.45-y EBITDA Growth Rate %35.4Current Ratio3.4Lower Leverage y-yN
Price/Free Cash Flow77.7y-y EBITDA Growth Rate %-26.9ROA % (ttm)1.3Higher Current Ratio y-yN
Dividend Yield %--PEG5.2ROE % (ttm)2.0Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M225ROIC % (ttm)1.9Gross Margin Increase y-yN

Gurus Latest Trades with ALXN

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
ALXNRon Baron 2015-12-31 Add0.02%$152.66 - $191.88
($175.28)
$ 139.28-21%Add 87.52%61,177
ALXNDavid Swensen 2015-09-30 Sold Out -16.37%$145.6 - $207.84
($182.41)
$ 139.28-24%Sold Out0
ALXNRon Baron 2015-09-30 Reduce-0.03%$145.6 - $207.84
($182.41)
$ 139.28-24%Reduce -53.24%32,624
ALXNMario Gabelli 2015-09-30 Sold Out $145.6 - $207.84
($182.41)
$ 139.28-24%Sold Out0
ALXNDavid Swensen 2015-06-30 Buy 16.37%$155.01 - $190.92
($172.58)
$ 139.28-19%New holding319,273
ALXNJoel Greenblatt 2015-06-30 Sold Out -0.03%$155.01 - $190.92
($172.58)
$ 139.28-19%Sold Out0
ALXNRon Baron 2015-06-30 Add0.02%$155.01 - $190.92
($172.58)
$ 139.28-19%Add 69.48%69,764
ALXNMario Gabelli 2015-06-30 Buy $155.01 - $190.92
($172.58)
$ 139.28-19%New holding1,415
ALXNJoel Greenblatt 2015-03-31 Reduce-0.09%$171.42 - $189.07
($181.01)
$ 139.28-23%Reduce -72.94%23,261
ALXNRon Baron 2015-03-31 Add0.02%$171.42 - $189.07
($181.01)
$ 139.28-23%Add 124.13%41,163
ALXNJoel Greenblatt 2014-12-31 Add0.13%$159.46 - $200.79
($185.68)
$ 139.28-25%Add 4665.74%85,974
ALXNRon Baron 2014-12-31 Add$159.46 - $200.79
($185.68)
$ 139.28-25%Add 41.92%18,366
ALXNJoel Greenblatt 2014-09-30 Reduce-0.03%$155.06 - $173.08
($164.22)
$ 139.28-15%Reduce -89.45%1,804
ALXNRon Baron 2014-09-30 Add$155.06 - $173.08
($164.22)
$ 139.28-15%Add 27.56%12,941
ALXNJoel Greenblatt 2014-06-30 Add0.02%$139.61 - $170.2
($157.93)
$ 139.28-12%Add 240.11%17,094
ALXNJoel Greenblatt 2014-03-31 Buy 0.01%$129.82 - $183.89
($158.27)
$ 139.28-12%New holding5,026
ALXNRon Baron 2014-03-31 Buy 0.01%$129.82 - $183.89
($158.27)
$ 139.28-12%New holding10,218
ALXNJoel Greenblatt 2013-03-31 Sold Out -0.07%$83.39 - $102.57
($93.13)
$ 139.2850%Sold Out0
ALXNJoel Greenblatt 2012-12-31 Buy 0.07%$87.97 - $118.15
($98.27)
$ 139.2842%New holding12,977
ALXNGeorge Soros 2012-06-30 Sold Out -0.07%$83.74 - $98.82
($91.04)
$ 139.2853%Sold Out0
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

ALXN is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


ALXN: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Hallal DavidCEO 2016-04-01Sell1,414$135.882.27view
O'Neill JulieEVP. Global Operations 2016-03-02Sell651$149.55-7.07view
Wagner Heidi LSVP, Global Government Affairs 2016-02-29Sell547$138.910.04view
Thiel CarstenEVP, Chief Commercial Officer 2016-02-29Sell54$138.910.04view
MACKAY MARTINEVP & Global Head of R&D 2016-02-29Sell1,000$138.910.04view
Miller EdwardSVP, Chief Compliance Officer 2016-02-29Sell329$138.910.04view
Islam SaqibEVP, Chief Strat & Port. Off. 2016-02-29Sell905$138.910.04view
Sinha VikasEVP & CFO 2016-02-29Sell1,122$138.910.04view
O'Neill JulieEVP. Global Operations 2016-02-29Sell663$138.910.04view
Moriarty John BEVP & General Counsel 2016-02-29Sell1,201$138.910.04view

Quarterly/Annual Reports about ALXN:

News about ALXN:

Articles On GuruFocus.com
Baron Funds Comments on Alexion Pharmaceuticals Feb 08 2016 
Weekly CFO Sales Highlight: H&R Block, DISH Network, Alexion Pharmaceuticals Jan 03 2016 
Weekly CFO Sells Highlight: Tyson Foods, Alexion Pharmaceuticals, Gilead Sciences Dec 13 2015 
Weekly Insider Sells Highlights: CDW, Twitter, P&G, Alexion Pharmaceuticals Dec 10 2015 
Alexion Pharmaceuticals Loses Position in Swensen's Portfolio Dec 03 2015 
Jim Simons' Largest Adds of the 3rd Quarter Nov 13 2015 
Baron Funds Comments on Alexion Pharmaceuticals Inc. Nov 10 2015 
Frank Sands Shows Bold Side in Second-Quarter Trades Sep 13 2015 
David Swensen Buys Stake in Vanguard MSCI Emerging Markets ETF Aug 19 2015 
Baron Funds Comments on Alexion Pharmaceuticals Inc. Aug 19 2015 

More From Other Websites
Alexion Pharmaceuticals, Inc. :ALXN-US: Earnings Analysis: Q1, 2016 By the Numbers May 02 2016
Analysts Make Major Changes to Top Biotech Ratings May 01 2016
ALEXION PHARMACEUTICALS INC Files SEC form 10-Q, Quarterly Report Apr 29 2016
Alexion Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : ALXN-US :... Apr 29 2016
ALEXION PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition,... Apr 28 2016
How Did XBI’s Large Caps Perform? Apr 28 2016
Edited Transcript of ALXN earnings conference call or presentation 28-Apr-16 2:00pm GMT Apr 28 2016
Alexion (ALXN) Lags Q1 Earnings & Revenues, Revises View Apr 28 2016
Sanofi launches $9.3 billion fight for U.S. cancer firm Medivation Apr 28 2016
Sanofi launches $9.3 bln fight for U.S. cancer firm Medivation Apr 28 2016
Sanofi launches $9.3 bln fight for U.S. cancer firm Medivation Apr 28 2016
Alexion (ALXN) Misses on Q1 Earnings and Revenues Apr 28 2016
[$$] Alexion Profit Declines but Revenue Rises Apr 28 2016
Q1 2016 Alexion Pharmaceuticals Inc Earnings Release - Before Market Open Apr 28 2016
Alexion misses Street 1Q forecasts Apr 28 2016
Alexion misses Street 1Q forecasts Apr 28 2016
Alexion Reports First Quarter 2016 Results Apr 28 2016
Alexion Reports First Quarter 2016 Results Apr 28 2016
Alexion (ALXN) Q1 Earnings: What's in Store for the Stock? Apr 26 2016
4 Biotechs That Will Escape Weak Seasonal Trends for the Sector Apr 26 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)